 |
| Hormone Replacement Therapy Market |
Hormone replacement therapy or HRT helps reduce many discomforting menopausal symptoms like hot flashes, night sweats, mood swings, vaginal dryness, etc. by replacing hormones that are low or missing due to menopause. It provides relief from menopausal symptoms and also helps in preventing or treating certain long-term health issues in postmenopausal women. The global Hormone Replacement Therapy Market is estimated to be valued at US$ 8.1 billion in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023.
Market key trends:
The increased demand for minimizing menopausal symptoms such as hot flashes,
vaginal dryness, and night sweats has accelerated the growth of the hormone
replacement therapy market. According to the North American Menopause Society,
>75% of women experience vasomotor symptoms during the menopausal transition
and early postmenopause. Hormone replacement therapy has proven to be an
effective way of managing these symptoms. It alleviates anxiety, mood swings, irritability
caused due to hormonal changes during menopause. This has driven more women to
opt for HRT to maintain their quality of life. The availability of various
product formulations like tablets, patches, and gels catering to individual
needs and lifestyles has also fueled the market growth.
Segment
Analysis
The global Hormone Replacement Therapy market is segmented on the basis of
therapy type, route of administration, and distribution channel. Based on
therapy type, the estrogen replacement therapy segment currently dominates the
market. This is because estrogen therapy helps in relieving symptoms of
menopause like hot flashes and night sweats. The route of administration
segment is divided into oral and topical. The oral segment holds a larger market
share due to ease of administration. The distribution channel segment includes
hospital pharmacies, retail pharmacies, and online pharmacies. Retail
pharmacies dominate as they provide convenient access.
Key Takeaways
The global Hormone
Replacement Therapy MARKET Trends is expected to witness high growth
over the forecast period of 2023.
Regional
analysis: In North America, the U.S. accounts for the largest share in the
Hormone Replacement Therapy market due to established healthcare infrastructure
and supportive reimbursement policies for menopause therapies. Europe follows
North America with the U.K. and Germany being the major revenue contributors.
Asia Pacific is expected to grow at the fastest rate led by emerging economies
like China and India experiencing increasing awareness of HRT to manage
menopause symptoms.
Key players: Key players operating in the Hormone Replacement Therapy market
are Pfizer Inc., Novartis, Bayer AG, Eli Lilly and Company, Merck KGaA. Pfizer
Inc. currently holds the leading position due to its broad product portfolio
for managing menopause through hormone therapies, which include Premarin and
Prempro.
For more insights, read- https://www.ukwebwire.com/hormone-replacement-therapy-market-trends-size-and-share-analysis/
For more details on the report, Read- https://cmiinfopiece.blogspot.com/2024/01/plant-based-meat-market-growth.html
0 Comments